Cargando…
A systematic review and meta-analysis on the effect of angiogenesis blockade for the treatment of gastric cancer
INTRODUCTION: To date, anti-vascular endothelial growth factor (VEGF) monoclonal antibody (mAb, bevacizumab), anti-VEGF receptor mAb (ramucirumab) and selective vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (sunitinib, sorafenib and apatinib) have been tested in the...
Autores principales: | Bai, Zhi-Gang, Zhang, Zhong-Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200090/ https://www.ncbi.nlm.nih.gov/pubmed/30410364 http://dx.doi.org/10.2147/OTT.S169484 |
Ejemplares similares
-
Editorial: Angiogenesis blockade for the treatment of gastrointestinal cancer
por: Passardi, Alessandro, et al.
Publicado: (2023) -
Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis
por: Yu, Jing, et al.
Publicado: (2016) -
Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
por: Yi, Ming, et al.
Publicado: (2019) -
Successes and failures of angiogenesis blockade in gastric and gastro-esophageal junction adenocarcinoma
por: Salati, Massimiliano, et al.
Publicado: (2022) -
A protocol of systematic review and meta-analysis of narrow band imaging endoscopy in detection of early gastric cancer
por: Zhang, Li, et al.
Publicado: (2020)